Table 2.
Outcome/subgroup | Women | Men | OR/B of women (95% CI) | P for interaction |
---|---|---|---|---|
In-hospital mortality | 0.188 | |||
PCI | 1277 (9.8%) | 1184 (9.1%) | 1.09 (1.001–1.19) | |
CABG | 360 (21.0%) | 371 (21.6%) | 0.96 (0.82–1.14) | |
IABP support | 0.070 | |||
PCI | 1435 (11.0%) | 1691 (12.9%) | 0.83 (0.77–0.90) | |
CABG | 660 (38.5%) | 677 (39.5%) | 0.96 (0.84–1.10) | |
ECMO support | 0.236 | |||
PCI | 95 (0.7%) | 147 (1.1%) | 0.64 (0.49–0.83) | |
CABG | 105 (6.1%) | 129 (7.5%) | 0.80 (0.62–1.05) | |
New onset ischemic stroke | 0.758 | |||
PCI | 235 (1.8%) | 197 (1.5%) | 1.20 (0.99–1.45) | |
CABG | 72 (4.2%) | 57 (3.3%) | 1.28 (0.90–1.82) | |
Pneumonia | 0.694 | |||
PCI | 995 (7.6%) | 1118 (8.6%) | 0.88 (0.81–0.96) | |
CABG | 162 (9.4%) | 190 (11.1%) | 0.84 (0.67–1.05) | |
GI bleeding | 0.825 | |||
PCI | 799 (6.1%) | 796 (6.1%) | 1.00 (0.91–1.11) | |
CABG | 74 (4.3%) | 71 (4.1%) | 1.04 (0.75–1.46) | |
New onset dialysis | 0.223 | |||
PCI | 784 (6.0%) | 740 (5.7%) | 1.07 (0.96–1.18) | |
CABG | 301 (17.5%) | 317 (18.5%) | 0.94 (0.79–1.12) | |
Prolonged ventilationa | 0.880 | |||
PCI | 1265 (9.7%) | 1242 (9.5%) | 1.02 (0.94–1.11) | |
CABG | 587 (34.2%) | 574 (33.4%) | 1.03 (0.90–1.19) | |
Hospital stays (days) | < 0.001 | |||
PCI | 10.6 ± 12.1 | 10.0 ± 11.8 | 0.69 (0.40, 0.98) | |
CABG | 28.3 ± 20.1 | 25.8 ± 18.8 | 2.5 (1.2, 3.8) | |
ICU duration (days) | 0.007 | |||
PCI | 4.9 ± 6.5 | 4.8 ± 6.4 | 0.17 (0.02, 0.33) | |
CABG | 13.0 ± 11.1 | 12.1 ± 10.8 | 0.87 (0.14, 1.60) | |
Medical expenditure (USD × 103) | 0.001 | |||
PCI | 7.8 ± 5.6 | 7.8 ± 5.7 | 0.04 (− 0.10, 0.17) | |
CABG | 20.1 ± 9.9 | 19.3 ± 9.7 | 0.78 (0.12, 1.44) |
Data were given as frequency (percentage%) or mean ± standard deviation
IABP intra-aortic balloon pumping, ECMO extra-corporeal membrane oxygenation, USD US dollars, OR odds ratio, B regression coefficient, CI confidence interval, ICU intensive care unit, USD US dollar
aThe dependence on mechanical ventilation for seven days or longer